MAP17 / PDZK1IP1 Polyclonal antibody, PBS Only
MAP17 / PDZK1IP1 Polyclonal Antibody for IHC, Indirect ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human
Applications
IHC, Indirect ELISA
Conjugate
Unconjugated
Cat no : 12518-1-PBS
Synonyms
Validation Data Gallery
Tested Applications
Recommended dilution
Application | Dilution |
---|---|
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. |
Product Information
12518-1-PBS targets MAP17 / PDZK1IP1 in IHC, Indirect ELISA applications and shows reactivity with human samples.
Tested Reactivity | human |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | MAP17 / PDZK1IP1 fusion protein Ag3206 相同性解析による交差性が予測される生物種 |
Full Name | PDZK1 interacting protein 1 |
Calculated molecular weight | 114 aa, 12 kDa |
GenBank accession number | BC012303 |
Gene symbol | MAP17 |
Gene ID (NCBI) | 10158 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
Storage Buffer | PBS Only |
Storage Conditions | Store at -80°C. |
Background Information
PDZK1-interacting protein 1(PDZK1IP1), also known as MAP17, is a membrane-associated protein. MAP17 / PDZK1IP1 is overexpressed in a variety of human carcinomas, and overexpression of MAP17 / PDZK1IP1 protein is strongly correlated with the progression of prostate and ovarian carcinomas (PMID: 17426052). MAP17 / PDZK1IP1 has been proven to be an oncogene for tumorigenesis and development of papillary thyroid cancer (PTC) (PMID: 36057192; PMID: 35727731).